Related references
Note: Only part of the references are listed.Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects
H-T Jin et al.
CANCER GENE THERAPY (2008)
Gene therapy clinical trials worldwide to 2007 - an update
Michael L. Edelstein et al.
JOURNAL OF GENE MEDICINE (2007)
Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12
Teruo Kaiga et al.
JOURNAL OF IMMUNOLOGY (2007)
Swords into plowshares: IL-23 repurposes tumor immune surveillance
John L. Langowski et al.
TRENDS IN IMMUNOLOGY (2007)
IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection
Euan Lockhart et al.
JOURNAL OF IMMUNOLOGY (2006)
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
Jinwei Hu et al.
CANCER RESEARCH (2006)
Understanding the IL-23-IL-17 immune pathway
BS McKenzie et al.
TRENDS IN IMMUNOLOGY (2006)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors
R Bilbao et al.
GENE THERAPY (2003)
Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects
S Ugai et al.
CANCER GENE THERAPY (2003)
Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells
YQ Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Antitumor and antimetastatic activity of IL-23
CH Lo et al.
JOURNAL OF IMMUNOLOGY (2003)
Cutting edge:: Roles of toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection
KI Happel et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells
ML Belladonna et al.
JOURNAL OF IMMUNOLOGY (2002)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism
F Benchetrit et al.
BLOOD (2002)
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice
P Nanni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense
P Ye et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
Share Paper
